Low herpesvirus entry mediator (HVEM) expression on dermal fibroblasts contributes to a Th2-dominant microenvironment in advanced cutaneous T-cell lymphoma

Journal of Investigative Dermatology

Volumn 132, Issue 4, 2012, Pages 1280-1289

  Miyagaki, Tomomitsu ^a   Sugaya, Makoto ^a   Suga, Hiraku ^a   Morimura, Sohshi ^a   Ohmatsu, Hanako ^a   Fujita, Hideki ^a   Asano, Yoshihide ^a   Tada, Yayoi ^a   Kadono, Takafumi ^a   Sato, Shinichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HERPESVIRUS ENTRY MEDIATOR; LYMPHOTOXIN LIKE RECEPTOR EXPRESSED BY T LYMPHOCYTES; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; FEMALE; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SKIN FIBROBLAST; TH2 CELL; TUMOR MICROENVIRONMENT;

EID: 84858294918     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.470     Document Type: Article

References (48)

1. Annunziato F, Galli G, Cosmi L et al. (1998) Molecules associated with human Th1 or Th2 cells. Eur Cytokine Netw 9:12-5
2. Asadullah K, Döcke WD, Haeussler A et al. (1996a) Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 mRNA. J Invest Dermatol 107:833-7
3. Asadullah K, Haeussler A, Sterry W et al. (1996b) Interferon gamma and tumor necrosis factor alpha mRNA expression in mycosis fungoides progression. Blood 88:757-8
4. Asano Y, Ihn H, Yamane K et al. (2004) Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. J Clin Invest 113:253-64
5. Browning JL, French LE (2002) Visualization of lymphotoxin-beta and lymphotoxin-beta receptor expression in mouse embryos. J Immunol 168:5079-87
6. Chandran V, Cook RJ, Edwin J et al. (2010) Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis. Rheumatology (Oxford) 49:1399-405
7. Duhen T, Pasero C, Mallet F et al. (2004) LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T celldependent B cell terminal differentiation. Eur J Immunol 34:3534-41
8. Dummer R, Geertsen R, Ludwig E et al. (1998) Sézary syndrome, T-helper 2 cytokines and accessory factor-1 (AF-1). Leuk Lymphoma 28:515-22
9. Endres R, Alimzhanov MB, Plitz T et al. (1998) Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells. J Exp Med 189:159-68
10. Fan Z, Yu P, Wang Y et al. (2006) NK-cell activation by LIGHT triggers tumorspecific CD8+ T-cell immunity to reject established tumors. Blood 107:1342-51
11. Ferenczi K, Fuhlbrigge RC, Pinkus J et al. (2002) Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol 119:1405-10
12. Force WR, Walter BN, Hession C et al. (1995) Mouse lymphotoxin-beta receptor. Molecular genetics, ligand binding, and expression. J Immunol 155:5280-8
13. Fujita H, Asahina A, Sugaya M et al. (2005) Differential production of Th1- and Th2-type chemokines by mouse Langerhans cells and splenic dendritic cells. J Invest Dermatol 124:343-50
14. Granger SW, Ware CF (2001) Turning on LIGHT. J Clin Invest 108:1741-2
15. Hardaker EL, Bacon AM, Carlson K et al. (2004) Regulation of TNF-Alpha- and IFN-gamma-induced CXCL10 expression: Participation of the airway smooth muscle in the pulmonary inflammatory response in chronic obstructive pulmonary disease. FASEB J 18:191-3
16. Harrop JA, Reddy M, Dede K et al. (1998) Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines. J Immunol 161:1786-94
17. Harwix S, Zachmann K, Neumann C (2000) T-cell clones from early-stage cutaneous T-cell lymphoma show no polarized Th-1 or Th-2 cytokine profile. Arch Dermatol Res 292:1-8
18. Hosokawa Y, Hosokawa I, Ozaki K et al. (2010) TNFSF14 coordinately enhances CXCL10 and CXCL11 productions from IFN-gamma-stimulated human gingival fibroblasts. Mol Immunol 47:666-70
19. Kakinuma T, Sugaya M, Nakamura K et al. (2003) Thymus and activationregulated chemokine (TARC) in mycosis fungoides: Serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol 48:23-30
20. Kallinich T, Muche JM, Qin S et al. (2003) Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides. J Invest Dermatol 121:1045-52
21. Kanda N, Shimizu T, Tada Y et al. (2007) IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes. Eur J Immunol 37:338-50
22. Kanda N, Watanabe S (2007) Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes. Endocrinology 148:2317-25
23. Kaplan EH, Rosen ST, Norris DB et al. (1990) Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst 82:208-12
24. Kim WJ, Kang YJ, Koh EM et al. (2005) LIGHT is involved in the pathogenesis of rheumatoid arthritis by inducing the expression of pro-inflammatory cytokines and MMP-9 in macrophages. Immunology 114:272-9
25. Lu D, Duvic M, Medeiros LJ et al. (2001) The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides. Am J Clin Pathol 115:413-21
26. Marsters SA, Ayres TM, Skubatch M et al. (1997) Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-Associated factor family and activates the transcription factors NF-kappaB and AP-1. J Biol Chem 272:14029-32
27. Mauri DN, Ebner R, Montgomery RI et al. (1998) LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8:21-30
28. Miyagaki T, Sugaya M, Fujita H et al. (2010) Eotaxins and CCR3 interaction regulates the Th2 environment of cutaneous T-cell lymphoma. J Invest Dermatol 130:2304-11
29. Morel Y, Schiano de Colella JM, Harrop J et al. (2000) Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor. J Immunol 165:4397-404
30. Morel Y, Truneh A, Sweet RW et al. (2001) The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J Immunol 167:2479-85
31. Murphy M, Walter BN, Pike-Nobile L et al. (1998) Expression of the lymphotoxin beta receptor on follicular stromal cells in human lymphoid tissues. Cell Death Differ 5:497-505
32. Papadavid E, Economidou J, Psarra A et al. (2003) The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome. Br J Dermatol 148:709-18
33. Pasero C, Barbarat B, Just-Landi S et al. (2009) A role for HVEM, but not lymphotoxin-beta receptor, in LIGHT-induced tumor cell death and chemokine production. Eur J Immunol 39:2502-14
34. Pierer M, Brentano F, Rethage J et al. (2007) The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis. Rheumatology (Oxford) 46:1063-70
35. Shi G, Luo H, Wan X et al. (2002) Mouse T cells receive costimulatory signals from LIGHT, a TNF family member. Blood 100:3279-85
36. Sokolowska-Wojdylo M, Wenzel J, Gaffal E et al. (2005) Circulating clonal CLA(+) and CD4(+) T cells in Sézary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph nodehoming chemokine receptor CCR7. Br J Dermatol 152:258-64
37. Sugaya M (2010) Chemokines and cutaneous lymphoma. J Dermatol Sci 59:81-5
38. Sugaya M, Fang L, Cardones AR et al. (2006) Oncostatin M enhances CCL21 expression by microvascular endothelial cells and increases the efficiency of dendritic cell trafficking to lymph nodes. J Immunol 177:7665-72
39. Tamada K, Shimozaki K, Chapoval AI et al. (2000) LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol 164:4105-10
40. Tensen CP, Vermeer MH, van der Stoop PM et al. (1998) Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas. J Invest Dermatol 111:222-5
41. Vowels BR, Cassin M, Vonderheid EC et al. (1992) Aberrant cytokine production by Sezary syndrome patients: Cytokine secretion pattern resembles murine Th2 cells. J Invest Dermatol 99:90-4
42. Vowels BR, Lessin SR, Cassin M et al. (1994) Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol 103:669-73
43. Wenzel J, Tüting T (2008) An IFN-Associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in ''interface dermatitis''. J Invest Dermatol 128:2392-402
44. Willemze R, Jaffe ES, Burg G et al. (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105:3768-85
45. Xu G, Liu D, Okwor I et al. (2007) LIGHT Is critical for IL-12 production by dendritic cells, optimal CD4+ Th1 cell response, and resistance to Leishmania major. J Immunol 179:6901-9
46. Yagi H, Seo N, Ohshima A et al. (2006) Chemokine receptor expression in cutaneous T cell and NK/T-cell lymphomas: Immunohistochemical staining and in vitro chemotactic assay. Am J Surg Pathol 30:1111-9
47. Yu KY, Kwon B, Ni J et al. (1999) A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem 274:13733-5
48. Zhai Y, Guo R, Hsu TL et al. (1998) LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest 102:1142-51